IL-1ß impedes the chondrogenic differentiation of synovial fluid mesenchymal stem cells in the human temporomandibular joint

International Journal of Molecular Medicine

Volumn 39, Issue 2, 2017, Pages 317-326

  Liu, Wenjing ^a,b   Sun, Yangpeng ^a   He, Yiqing ^a   Zhang, Hong ^a   Zheng, Youhua ^a   Yao, Yu ^a   Zhang, Zhiguang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Arthritis; Cytokines; Mesenchymal stem cells; Synovial fluid; Temporomandibular

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 5' NUCLEOTIDASE; CD11B ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COLLAGENASE 3; CYTOKINE; ENDOGLIN; GLYCOSAMINOGLYCAN POLYSULFATE; HERMES ANTIGEN; HLA DR ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12P; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID; BIOLOGICAL MARKER; MEMBRANE ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MALE; MESENCHYMAL STEM CELL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; UPREGULATION; CHONDROGENESIS; CYTOLOGY; DRUG EFFECTS; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PHENOTYPE;

ANTIGENS, SURFACE; BIOMARKERS; CELL DIFFERENTIATION; CHONDROGENESIS; CYTOKINES; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MESENCHYMAL STROMAL CELLS; NEUROGENESIS; NF-KAPPA B; PHENOTYPE; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT;

EID: 85012050807     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2832     Document Type: Article

References (41)

1. Gauer RL and Semidey MJ: Diagnosis and treatment of temporomandibular disorders. Am Fam Physician 91: 378-386, 2015.
2. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P and McGonagle D: Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 50: 817-827, 2004.
3. Zhang S, Muneta T, Morito T, Mochizuki T and Sekiya I: Autologous synovial fluid enhances migration of mesenchymal stem cells from synovium of osteoarthritis patients in tissue culture system. J Orthop Res 26: 1413-1418, 2008.
4. Harvanová D, Tóthová T, Sarišský M, Amrichová J and Rosocha J: Isolation and characterization of synovial mesenchymal stem cells. Folia Biol (Praha) 57: 119-124, 2011.
5. Koyama N, Okubo Y, Nakao K, Osawa K, Fujimura K and Bessho K: Pluripotency of mesenchymal cells derived from synovial fluid in patients with temporomandibular joint disorder. Life Sci 89: 741-747, 2011.
6. Sun YP, Zheng YH, Liu WJ, Zheng YL and Zhang ZG: Synovium fragment-derived cells exhibit characteristics similar to those of dissociated multipotent cells in synovial fluid of the temporomandibular joint. PLoS One 9: E101896, 2014.
7. Sullivan C, Murphy JM, Griffin MD, Porter RM, Evans CH, O'Flatharta C, Shaw G and Barry F: Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis. Arthritis Res Ther 14: R167, 2012.
8. Papadopoulou A, Yiangou M, Athanasiou E, Zogas N, Kaloyannidis P, Batsis I, Fassas A, Anagnostopoulos A and Yannaki E: Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis 71: 1733-1740, 2012.
9. Jones EA, Crawford A, English A, Henshaw K, Mundy J, Corscadden D, Chapman T, Emery P, Hatton P and McGonagle D: Synovial fluid mesenchymal stem cells in health and early osteoarthritis: Detection and functional evaluation at the single-cell level. Arthritis Rheum 58: 1731-1740, 2008.
10. Sekiya I, Ojima M, Suzuki S, Yamaga M, Horie M, Koga H, Tsuji K, Miyaguchi K, Ogishima S, Tanaka H and Muneta T: Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J Orthop Res 30: 943-949, 2012.
11. Lee DH, Sonn CH, Han SB, Oh Y, Lee KM and Lee SH: Synovial fluid CD34- CD44+ CD90+ mesenchymal stem cell levels are associated with the severity of primary knee osteoarthritis. Osteoarthritis Cartilage 20: 106-109, 2012.
12. Neidhart M, Seemayer CA, Hummel KM, Michel BA, Gay RE and Gay S: Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: Destructive potential in vitro and in vivo. Arthritis Rheum 48: 1873-1880, 2003.
13. Heldens GT, Blaney Davidson EN, Vitters EL, Schreurs BW, Piek E, van den Berg WB and van der Kraan PM: Catabolic factors and osteoarthritis-conditioned medium inhibit chondrogenesis of human mesenchymal stem cells. Tissue Eng Part A 18: 45-54, 2012.
14. Boeuf S, Graf F, Fischer J, Moradi B, Little CB and Richter W: Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells. Eur Cell Mater 23: 320-332, 2012.
15. Li J, Long X, Ke J, Meng QG, Lee WC, Doocey JM and Zhu F: Regulation of HAS expression in human synovial lining cells of TMJ by IL-1beta. Arch Oral Biol 53: 60-65, 2008.
16. Alstergren P, Ernberg M, Kvarnström M and Kopp S: Interleukin-1beta in synovial fluid from the arthritic temporo-mandibular joint and its relation to pain, mobility, and anterior open bite. J Oral Maxillofac Surg 56: 1059-1066, 1998.
17. Kristensen KD, Alstergren P, Stoustrup P, Küseler A, Herlin T and Pedersen TK: Cytokines in healthy temporomandibular joint synovial fluid. J Oral Rehabil 41: 250-256, 2014.
18. Marks PH and Donaldson ML: Inflammatory cytokine profiles associated with chondral damage in the anterior cruciate ligament-deficient knee. Arthroscopy 21: 1342-1347, 2005.
19. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U and Poole AR: Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 52: 128-135, 2005.
20. Fan Z, Söder S, Oehler S, Fundel K and Aigner T: Activation of interleukin-1 signaling cascades in normal and osteoarthritic articular cartilage. Am J Pathol 171: 938-946, 2007.
21. Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, El Hachem K, Hashimoto K, Roach HI, Olivotto E, Borzi RM, et al: Roles of inflammatory and anabolic cytokines in cartilage metabolism: Signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater 21: 202-220, 2011.
22. Tang J, Cui W, Song F, Zhai C, Hu H, Zuo Q and Fan W: Effects of mesenchymal stem cells on interleukin-1ß-treated chondrocytes and cartilage in a rat osteoarthritic model. Mol Med Rep 12: 1753-1760, 2015.
23. Fricton JR and Schiffman EL: Reliability of a craniomandibular index. J Dent Res 65: 1359-1364, 1986.
24. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj and Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317, 2006.
25. Keating A: Mesenchymal stromal cells: New directions. Cell Stem Cell 10: 709-716, 2012.
26. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H and Sekiya I: Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 327: 449-462, 2007.
27. Ogata Y, Mabuchi Y, Yoshida M, Suto EG, Suzuki N, Muneta T, Sekiya I and Akazawa C: Purified human synovium mesenchymal stem cells as a good resource for cartilage regeneration. PLoS One 10: E0129096, 2015.
28. Suzuki S, Muneta T, Tsuji K, Ichinose S, Makino H, Umezawa A and Sekiya I: Properties and usefulness of aggregates of synovial mesenchymal stem cells as a source for cartilage regeneration. Arthritis Res Ther 14: R136, 2012.
29. Ritchlin C: Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2: 356-360, 2000.
30. Kaneyama K, Segami N, Nishimura M, Suzuki T and Sato J: Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 40: 418-423, 2002.
31. Guttridge DC, Mayo MW, Madrid LV, Wang CY and Baldwin AS Jr: NF-kappaB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 289: 2363-2366, 2000.
32. Li X and Makarov SS: An essential role of NF-kappaB in the 'tumor-like' phenotype of arthritic synoviocytes. Proc Natl Acad Sci USA 103: 17432-17437, 2006.
33. Sitcheran R, Cogswell PC and Baldwin AS Jr: NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism. Genes Dev 17: 2368-2373, 2003.
34. Augello A, Tasso R, Negrini SM, Cancedda R and Pennesi G: Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56: 1175-1186, 2007.
35. van Buul GM, Villafuertes E, Bos PK, Waarsing JH, Kops N, Narcisi R, Weinans H, Verhaar JA, Bernsen MR and van Osch GJ: Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture. Osteoarthritis Cartilage 20: 1186-1196, 2012.
36. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C and Noël D: Reversal of the immunosup-pressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 52: 1595-1603, 2005.
37. Liu CH and Hwang SM: Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32: 270-279, 2005.
38. Djouad F, Bony C, Häupl T, Uzé G, Lahlou N, Louis-Plence P, Apparailly F, Canovas F, Rème T, Sany J, et al: Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7: R1304-R1315, 2005.
39. Nishimura M, Segami N, Kaneyama K, Suzuki T and Miyamaru M: Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 40: 68-71, 2002.
40. Fu K, Ma X, Zhang Z, Pang X and Chen W: Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9: 131-137, 1995.
41. Roman-Blas JA and Jimenez SA: NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 14: 839-848, 2006.